Main Article Content

Authors

Introduction: The aim of this study was to evaluate the salivary flow, the presence of oral symptoms, and the oral health-related quality of life perceptions among individuals with neuromuscular diseases. Materials and Methods: It is a cross-sectional study, with 30 individuals with neuromuscular diseases treated at a neurorehabilitation clinic of a Brazilian university hospital from October to December 2017. Anamnesis, assessment of resting salivary flow, and measurement of salivary pH were performed. The instrument Oral Health Impact Profile-14 was used to evaluate the oral health-related quality of life. Data were analyzed using descriptive analysis and chi-square test, using a 5% significance level (p <0.05). Results: Amyotrophic Lateral Sclerosis was the most common disease in the group (50 %). The mean resting salivary flow was 0.44 ml/min, where it was found 43.3 % of high salivary flow and 3.3 % of hypo-salivation. The mean salivary pH found was 6.47 ± 0.57, where 56.6 % of the patients had neutral pH and 40% low pH. The most prevalent oral symptoms were dysphagia (56.7%) and xerostomia (43.3%). The mean Oral Health Impact Profile-14 was 5.54 ± 4.93, with 90% of patients presenting some impact of oral conditions on quality of life. A statistically significant association (p <0.05) between the quality of life and symptoms of dysphagia, xerostomia, oral burning, and sialorrhea was found. The Oral Health Impact Profile-14 dimensions with the highest percentages were psychological inability (14.5%) and functional limitation (13.5 %). Conclusion: The majority of patients presented salivary gland dysfunction with high salivary flows. The presence of oral symptoms negatively influenced the individual’s quality of life perceptions of individuals with neuromuscular diseases.
Alves Ferreira, A. K., Freitas Teixeira de Argôlo, I., Marques Soares, M. S., & Brito Pereira de Melo, Ângelo. (2020). Salivary changes, oral symptoms, and oral health-related quality of life in patients with neuromuscular diseases. Revista Ciencias De La Salud, 18(1), 82–95. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.8765

Diniz GPC, Lasmar LMLBF, Gianetti JG. Doenças neuromusculares e instrumentos úteis na avaliação motora em crianças e adolescentes. Rev Med Minas Gerais. 2010;20(4):12-19.

Burns TM, Graham CD, Rose MR, Simmons Z. Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve. 2012;46(1):9-25.

Bergendal B, Mcallister A. Orofacial function and monitoring of oral care in amyotrophic lateral sclerosis. Acta Odontol Scand. 2017;75(3):1-10. Doi: 10.1080/00016357.2016.1276212

Mcgeachan AJ, Mcdermott CJ. Management of oral secretions in neurological disease. Pract Neurol. 2017;17(2):96-103. Doi: 10.1136/practneurol-2016-001515

Sivaramakrishnan G, Sridharan K. Adverse drug reactions in the oral cavity. Drugs Ther Perspect. 2016;32(7):297-303. Doi: 10.1007/s40267-016-0302-9

Ekström J, Castagnola M, Messana M. Saliva and the Control of Its Secretion. In: Ekberg O, editor. Dysphagia. Berlin: Springer; 2012. Doi: 10.1007/174_2011_481

Wayama MT, Aranega AM, Bassi APF, Ponzoni D, Garcia Junior IR. Grau de conhecimento dos cirurgiões-dentistas sobre Odontologia Hospitalar. Rev Bras Odont. 2014;71(1):48- 52. Doi: http://dx.doi.org/10.18363/rbo.v71i1.491

Bennadi D, Reddy CVK. Oral health related quality of life. J Int Soc Prev Community Dent. 2013;3(1):1-6. Doi: 10.4103/2231-0762.115700

Locker D, Matear D, Stephens M, Jokovic A. Oral health-related quality of life of a popula- tion of medically compromised elderly people. Community Dent Health. 2002;19(2):90-7.

Pupo DB, Bussoloti Filho I, Bianca ML, Gustavo PK. Proposta de um método prático de sialometria. Rev Bras Otorrinolaringol. 2002;68(2):219-222. Doi: 10.1590/S0034- 72992002000200010

Fallahi A, Khadivi N, Roohpour N, Middleton AM, Kazemzadeh-Narbat M, Annabi N, et al. Characterization, mechanistic analysis and improving the properties of denture adhesives. Dent Mater. 2018;34(1):120-131. Doi: 10.1016/j.dental.2017.09.015

Saleh J, Figueiredo ZMA, Cherubini K, Salum FG. Salivary hypofunction: An update on aetiology, diagnosis and therapeutics. Arch Oral Biol. 2015;60(2):242-255. Doi: 10.1016/j. archoralbio.2014.10.004

Silva JYB, Brancher JA, Duda JG, Losso EM. Mudanças do pH salivar em crianças após a ingestão de suco de frutas industrializado. RSBO. 2008;5(2):7-11.

Thomas-stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3:73-78. Doi: 10.1007/bf02412423

Costa CC, Ferreira JB. Aplicação de toxina botulínica nas glândulas salivares maiores para o tratamento de sialorréia crônica. Rev Bras Cir Cabeça Pescoço. 2008;37(1):28-31.

Oliveira BH, Nadanovsky P. Psychometric properties of the Brazilian version of the Oral Health Impact Profile - short form. Community Dent Oral Epidemiol. 2005;33(4):307-314. Doi: 10.1111/j.1600-0528.2005.00225.x

Slade GD, Spencer, AJ. Development and evaluation of the Oral Health Impact Profile. Community Den Health. 1994;11(1):3-11.

Bastos RS, Carvalho ES, Xavier A, Caldana ML, Bastos JR, Lauris JR. Dental caries related to quality of life in two Brazilian adolescent groups: A cross-sectional randomised study. Int Dent J. 2012;62:137-143. Doi: 10.1111/j.1875-595X.2011.00105.x

Allen PF, Locker D. Do item weights matter? An assessment using the oral health impact profile. Community Dent Health. 1997;14:133-138.

FGA SP, Lima JMB, Alvarenga RP. Epidemiologia da Esclerose Lateral Amiotrófica – Europa/América do Norte/América do Sul/Ásia. Discrepâncias e similaridades. Revisão sistemática da literatura. Rev Bras Neurol. 2009;45(2):5-10.

Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic la- teral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Sclerosis Frontotemporal Degener. 2014;15(1-2):106-13. Doi: 10.3109/21678421.2013.852590

Nakayama R, Nishiyama A, Matsuda C, Nakayama Y, Hakuta C, Shimada M. Oral health status of hospitalized amyotrophic lateral sclerosis patients: A single-centre observatio- nal study. Acta Odontol Scand. 2018;76(4):294-298. Doi: 10.1080/00016357.2017.1420228

Barber SC, Shaw JS. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48(5):629-41. Doi: 10.1016/j.freeradbio- med.2009.11.018

Nijima A. Reflex effects of oral, gastrointestinal and hepatoportal glutamate sensors on vagal nerve activity. J Nutr. 2000;130(4):971S-3S. Doi: 10.1093/jn/130.4.971S

Araujo APQC, Araujo IP, Araujo AQC. Autonomic nervous system dysfunction in motor neuron diseases. J Rare Dis Res Treat. 2018;3(1):1-5.

Charchaflie RJ, Bustos Fernandez L, Perec CJ, Gonzalez E, Marzi A. Functional studies of the parotid and pancreas glands in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1974;37:863-867.

Viana SMPO, Alvarenga P. Manifestações orofaríngeas na Esclerose Lateral Amiotrófica. Rev Neurocien. 2015;23(2):173-181. Doi: 10.4181/RNC.2015.23.02.928.9p

Pellegrini A, Lunetta C, Ferrarese C, Tremolizzo L. Sialorrhoea: how to manage a fre- quente complication of motor neuron disease. EMJ Neurol. 2015;3(1):107-113.

Dand P, Sakel M. The management of drooling in motor neurone disease. Int J Palliat Nurs. 2010;16(11):560-4. Doi: 10.12968/ijpn.2010.16.11.80024

Knuijt S, Kalf JG, de Swart BJ, Drost G, Hendricks HT, Geurts AC, et al. Dysarthria and dysphagia highly prevalent among various types of neuromuscular diseases. Disabil Rehabil. 2014;36(15)1285-9. Doi: 10.3109/09638288.2013.845255

Paris G, Martinaud O, Petit A, Cuvelier A, Hannequin D, Roppeneck P, et al. Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life. J Oral Rehabil. 2013;40:199- 204. Doi: 10.12968/ijpn.2010.16.11.80024

Müller F. Oral hygiene reduces the mortality from aspiration pneumonia in frail elders. J Dent Res. 2015;94(3):14-16. Doi: 10.1177/0022034514552494

Wolff A, et al. A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea. A systematic Review Sponsored by The World Workshop on Oral Medicine VI. Drugs R D. 2017;17:1-17. Doi: 10.1007/s40268-016-0153-9

Hopcraft MS, Tan C. Xerostomia: An update for clinicians. Aust Dent J. 2010;55:238–244.

Molania T, Alimohammadi M, Akha O, Mousavi J, Razvini R, Salehi R. The effect of xeros- tomia and hyposalivation on the quality of life of patients with type II diabetes mellitus. Electron Physician 2017;9(11): 5814–5819. Doi: 10.19082/5814

Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M. Risk factors, hyposa- livation and impact of xerostomia on oral health-related quality of life. Braz. Oral Res. 2017;31:1-9. Doi: 10.1590/1807-3107BOR-2017.vol31.0014

Downloads

Download data is not yet available.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.